Abstract
Objective: Sentinel lymph node biopsy (SLNB) for invasive vulvar carcinoma has been validated by two large trials: GROINSS-V and GOG 173. Our study aims to identify the national patterns of practice of SLNB for invasive squamous cell carcinoma of the vulva (SCC) and to identify any disparities in its utilization.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
